SCHEMBL7299146

SCHEMBL7299146

NC(=O)c1cccc2c1OCCN2

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.57
AURKA O14965 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
AKT1 P31749 1/20 0.38
AR P10275 1/20 0.37
HDAC11 Q96DB2 1/20 0.36
PDPK1 O15530 1/20 0.36
TRPA1 O75762 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1340046 0.85 ALOX5 (0.40) PARP1ADORA2AADORA1AKT1AR
SCHEMBL18665582 0.84 KDM4E (0.43) PARP1ADORA2AADORA1AKT1AR
SCHEMBL1340430 0.80 ALOX5 (0.45) ADORA2AADORA1HDAC11TRPA1KDM4E
SCHEMBL21316386 0.80 ADORA2A (0.38) PARP1ADORA2AADORA1AKT1AR
SCHEMBL1612190 0.77 TSHR (0.49) ALDH1A1MAPTTSHRHSD17B10
SCHEMBL1549847 0.77 ADRA1D (0.43) ADORA2AADORA1AKT1HDAC11ALDH1A1
SCHEMBL14541030 0.77 CREBBP (0.41) ADORA2AADORA1MAPT
SCHEMBL1548498 0.76 ALOX5 (0.38) PARP1ADORA2AADORA1AKT1KDM4E
SCHEMBL22607785 0.74 PARP1 (0.45) PARP1AURKACYP11B1CYP11B2HDAC11
SCHEMBL1027825 0.74 DRD2 (0.39) PARP1ADORA2AADORA1AKT1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2723717-A2 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS Amgen Inc. (US) 2014-04-30 EP claimed
WO-2012177893-A2 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2012-12-27 WO claimed
EP-2314585-B1 Condensed benzamide compounds as inhibitors of vanilloid receptor subtype 1 (VR1) activity JAPAN TOBACCO INC (JP) 2012-09-12 EP claimed
WO-2001009127-A1 BENZOXAZINE DERIVATIVES AND THEIR THERAPEUTIC USE AVENTIS PHARMA S.A. (FR) 2001-02-08 WO claimed
EP-2723717-A2 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS Amgen Inc. (US) 2014-04-30 EP disclosed
WO-2012177893-A2 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2012-12-27 WO disclosed
WO-2001009127-A1 BENZOXAZINE DERIVATIVES AND THEIR THERAPEUTIC USE AVENTIS PHARMA S.A. (FR) 2001-02-08 WO disclosed
EP-0407137-A2 Benzazine compounds and pharmaceutical uses thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1991-01-09 EP disclosed